Skip to search formSkip to main contentSkip to account menu

CB 7646

Known as: CB-7646 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Pre‐clinical development of the anti‐tumour agent CB 7646, BIS N‐(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol
Formulation difficulties prevented the otherwise promising clinical development of the anti‐tumour agent trimelamol (TM; tris… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)